Techlife Capital
Techlife Capital is a Paris-based growth equity firm founded in 2018. The firm specializes in making growth buy-out investments in companies within the healthcare and technology sectors. By focusing on these industries, Techlife Capital aims to support the development and expansion of innovative businesses that contribute to advancements in health and technology.
2 past transactions
Flash Therapeutics
Debt Financing in 2021
Flash Therapeutics specializes in genomic medicine, utilizing viral vector technologies to develop gene therapies. It offers solutions such as gene silencing, over-expression, cell-based assay development, protein expression, and preclinical trials. The company manufactures ready-to-use lentiviral particles for cellular reprogramming and fluorescent protein expression.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.